Botulinum Neurotoxin-A Injection in Adult Cervical Dystonia and Spastic Paresis: Results From the INPUT (INjection Practice, Usage and Training) Survey.

Botulinum toxin-A cervical dystonia continuous medical education (CME) patient management practices rehabilitation spastic paresis

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2020
Historique:
received: 08 06 2020
accepted: 13 08 2020
entrez: 12 10 2020
pubmed: 13 10 2020
medline: 13 10 2020
Statut: epublish

Résumé

Botulinum toxin-A (BoNT-A) is an effective treatment for cervical dystonia (CD) and spastic paresis (SP), but it requires in-depth knowledge of anatomy and injection techniques. The Ixcellence Network® is an educational programme to provide neurology, neuropaediatrics, and physical medicine and rehabilitation (PMR) specialists with access to best clinical practices and innovations regarding SP and CD management with BoNT-A. To assess the benefits of such educational programmes and identify unmet needs, a multidisciplinary scientific committee designed INPUT (INjection Practice, Usage & Training), an international multicentric survey describing training and practices among this trained and experienced population. A self-completed questionnaire was sent online to 553 trainees and 14 trainers from the Ixcellence Network®. Among the 131 respondents, 92% specialized in PMR (48%) or neurology (44%), with a mean experience of 15.5 years in their clinical fields and 10.9 years of BoNT-A injection. Most of them (98%) reported having received training before performing their first BoNT-A injection and attending specific courses on how to perform it without any instrumental guidance (76%), and with ultrasound (73%), electrical stimulation (44%) or electromyography (41%). In terms of practices, 92% of respondents reported using at least one guidance technique while injecting, with ultrasound being the most used technique (48%). Attending specific courses was significantly associated with greater self-confidence and use, e.g. for injection with ultrasound, mean self-confidence, on a scale from 1 (not confident) to 10 (fully confident), was 7.9 for trained respondents (vs 4.0 for untrained respondents,

Identifiants

pubmed: 33041997
doi: 10.3389/fneur.2020.570671
pmc: PMC7525121
doi:

Types de publication

Journal Article

Langues

eng

Pagination

570671

Informations de copyright

Copyright © 2020 Chung, Jacinto, Colosimo, Bhatia, Tiley and Bhidayasiri.

Références

Mov Disord Clin Pract. 2015 May 07;2(3):224-226
pubmed: 30838229
Drug Des Devel Ther. 2016 Mar 08;10:1085-99
pubmed: 27022247
J Rehabil Med. 2007 Jan;39(1):33-7
pubmed: 17225035
Acta Neurol Belg. 2020 Jun;120(3):639-643
pubmed: 29978276
Aust Occup Ther J. 2012 Aug;59(4):257-64
pubmed: 22934898
J Neurol. 2016 Jun;263(6):1188-94
pubmed: 27113604
Eur J Neurol. 2011 Jan;18(1):5-18
pubmed: 20482602
Neurol Int. 2015 Sep 24;7(2):5886
pubmed: 26487928
Neurology. 2016 Mar 15;86(11):e112-7
pubmed: 26976522
Toxins (Basel). 2018 Jun 21;10(7):
pubmed: 29933562
Nervenarzt. 2017 Aug;88(8):919-928
pubmed: 28289789
Funct Neurol. 2017 Apr/Jun;32(2):103-110
pubmed: 28676144
Arch Phys Med Rehabil. 2015 Nov;96(11):2067-78.e1
pubmed: 25982240
Aust Occup Ther J. 2015 Feb;62(1):27-40
pubmed: 25649033
J Neurol. 2015 Oct;262(10):2201-13
pubmed: 25877834
J Rehabil Med. 2009 Jan;41(1):13-25
pubmed: 19197564
Clin Rehabil. 2014 Mar;28(3):232-42
pubmed: 23945164
Can J Neurol Sci. 2012 Jul;39(4):508-15
pubmed: 22728860
J Neurol Sci. 2013 Dec 15;335(1-2):72-4
pubmed: 24034410
BMC Med Res Methodol. 2015 Apr 09;15:32
pubmed: 25888346
Disabil Rehabil. 2019 Mar;41(6):720-726
pubmed: 29126361
Eur J Neurol. 2010 Aug;17 Suppl 2:57-73
pubmed: 20633179
J Clin Neurosci. 2016 Mar;25:62-4
pubmed: 26601813
Parkinsonism Relat Disord. 2019 Jun;63:195-198
pubmed: 30837195
Neurol Clin Pract. 2019 Feb;9(1):64-73
pubmed: 30859009
Clin Ther. 2019 Nov;41(11):2321-2330.e4
pubmed: 31607560
Toxins (Basel). 2015 May 11;7(5):1629-48
pubmed: 25969944
Disabil Rehabil. 2016 Jul;38(15):1431-1441
pubmed: 26713898
J Rehabil Med. 2011 Nov;43(11):1032-7
pubmed: 22031350
J Neurol. 2015;262(4):837-48
pubmed: 25605434
Eur J Neurol. 2006 Dec;13 Suppl 4:20-6
pubmed: 17112346
Clin Rehabil. 2005 Mar;19(2):117-25
pubmed: 15759526
Arch Phys Med Rehabil. 2018 May;99(5):1011-1022.e1
pubmed: 29357280
BMJ Open. 2013 Jun 20;3(6):
pubmed: 23794582
Clin Rehabil. 2017 Jun;31(6):713-721
pubmed: 27370102

Auteurs

Tae Mo Chung (TM)

Faculty of Medicine, Institute of Physical Medicine and Rehabilitation, University of São Paulo, São Paulo, Brazil.

Luis Jorge Jacinto (LJ)

Serviço de Reabilitação de adultos, Centro de Medicina de Reabilitacao do Alcoitão, Alcabideche, Portugal.

Carlo Colosimo (C)

Department of Neurology, Azienda Ospedaliera S.Maria, Terni, Italy.

Kailash P Bhatia (KP)

Institute of Neurology, University College London, London, United Kingdom.

Julie Tiley (J)

Global Medical Affairs, Ipsen, Boulogne Billancourt, France.

Roongroj Bhidayasiri (R)

Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

Classifications MeSH